10x Genomics, Inc. Quarterly Debt-to-equity in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
10x Genomics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q2 2024.
  • 10x Genomics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 28.6 %, a 6.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 28.6 +1.77 +6.6% Jun 30, 2024
Q1 2024 27.6 +0.04 +0.15% Mar 31, 2024
Q4 2023 27.1 +0.05 +0.19% Dec 31, 2023
Q3 2023 26.5 +0.25 +0.95% Sep 30, 2023
Q2 2023 26.8 +1.67 +6.65% Jun 30, 2023
Q1 2023 27.6 +3.23 +13.3% Mar 31, 2023
Q4 2022 27.1 +2.14 +8.59% Dec 31, 2022
Q3 2022 26.3 +1.07 +4.25% Sep 30, 2022
Q2 2022 25.1 -0.74 -2.86% Jun 30, 2022
Q1 2022 24.3 -5.23 -17.7% Mar 31, 2022
Q4 2021 24.9 -8.94 -26.4% Dec 31, 2021
Q3 2021 25.2 -13.7 -35.3% Sep 30, 2021
Q2 2021 25.9 -18.6 -41.8% Jun 30, 2021
Q1 2021 29.6 Mar 31, 2021
Q4 2020 33.9 Dec 31, 2020
Q3 2020 38.9 Sep 30, 2020
Q2 2020 44.5 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.